Matrine-Induced Apoptosis in Leukemia U937 Cells: Involvement of Caspases Activation and MAPK-Independent Pathways

Abstract

It is reported that matrine, one of the major effective compounds isolated from the root of Sophora flavescens Ait., has anti-leukemia activity. In this study, we find that the treatment of leukemia U937 cells with matrine results in induction of apoptosis. Analysis of the mechanism underling this apoptotic event showed activation of caspases-9, -3, and -7, and release of cytochrome C from mitochondria to cytosol, and cleavage of poly(ADP-ribose) polymerase. Matrine did not alter the level of bcl-2 and bcl-xL as well as bax. In addition, no correlation was found between matrine administration and activation of the three major MAPK subfamilies (Erk1/2, p38, JNK/SAPK). The results indicate that matrine induces apoptosis in U937 cells via a cytochrome C-triggered caspase activation pathway.

Abbreviations

MAPK:mitogen activated protein kinase

JUN/SAPKs:c-Jun N-terminal kinases/stress-activated protein
kinases

Erk1/2:extracellular signal-related kinases

Key words

Sophora - Leguminosae - matrine - apoptosis - caspase - cytochrome C - MAPK

References

• 1 Niu K Z. Pharmacology and clinical application of Sophora flavescentis .  Int J Oriental Med. 1997;  22 75-81
• 2 Cai X, Wang G J, Zai Y, Fan C H, Zhang R Q, Xu W S. Analysis of efficacy of matrine injection in treatment of chronic hepatitis B.  Acad J Second Military Med Univ. 1997;  18 47-9
• 3 Zhang L P, Jiang J K, Tam J W, Zhang Y, Liu X S, Xu X R. et al . Effects of matrine on proliferation and differentiation in K-562 cells.  Leuk Res. 2001;  25 793-800
• 4 Reed J. Dysregulation of apoptosis in cancer.  J Clin Oncol. 1999;  17 2941-53
• 5 Kaufmann S H, Earnshaw W C. Induction of apoptosis by cancer chemotherapy.  Exp Cell Res. 2000;  256 42-9
• 6 Cryns V, Yuan Y. Proteases to die for.  Genes Dev. 1998;  12 1551-70
• 7 Cohen G M. Caspases: the executioners of apoptosis.  Biochem J. 1997;  326 1-16
• 8 Srinivasula S M, Ahmad M, Fernandes-Alnemri T, Alnemri E S. Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization.  Mol Cell. 1998;  1 949-57
• 9 Cross T G, Scheel-Toellner D, Henriquez N V, Deacon E, Salmon M, Lord J M. Serine/threonine protein kinases and apoptosis.  Exp Cell Res. 2000;  256 34-41
• 10 Xia Z, Dickens M, Raingeaud J, Davis R, Greenberg M E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis.  Science. 1995;  270 1326-31
• 11 Kang C D, Yoo S D, Hwang B W, Kim K W, Kin D W, Kim C M. et al . The inhibition of ERK/MAPK not the activation of JNK/SAPK is primarily required to induce apoptosis in chronic myelogenous leukemic K562cells.  Leuk Res. 2000;  24 527-34
• 12 Dorsey J F, Jove R, Kraker A J, Wu J. The pyrido[2,3-d]pyrimidine derivative PD180970 inhibits p210Bcr-Abl tyrosine kinase and induces apoptosis of K562 leukemic cells.  Cancer Res. 2000;  60 3127-31
• 13 Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.  Immunol Methods. 1983;  65 55-63
• 14 Kantarjian H M, Talpaz M, Santini V, Murgo A, Cheson B, O'Brien S M. Homoharringtonine: history, current research, and future direction.  Cancer. 2001;  92 1591-605
• 15 Deininger M W, Goldman J M, Lydon N, Melo J V. The tyrosine kinase inhibitor CGP57148B selectively inhibits the growth of BCR-ABL-positive cells.  Blood. 1997;  90 3691-8
• 16 Daniel P T. Dissecting the pathways to death.  Leukemia. 2000;  14 2035-44
• 17 Sun X M, MacFarlane M, Zhuang J, Wolf B B, Green D R, Cohen G M. Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis.  J Biol Chem. 1999;  274 5053-60
• 18 Stroh C, Schulze-Osthoff K. Death by a thousand cuts: an ever increasing list of caspase substrates.  Cell Death Differ. 1998;  5 997-1000
• 19 Li P, Nijhawan D, Budihardjo I, Srinivasula S M, Ahmad M, Alnemri E S. et al . Cytochrome C and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade.  Cell. 1997;  91 479-89
• 20 Slee E A, Harte M T, Kluck R M, Wolf B B, Casiano C A, Newmeyer D D. et al . Ordering the cytochrome C-initiated caspase cascade: hierarchical activation of caspase-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner.  J Cell Biol. 1999;  144 281-92
• 21 Adams J M, Cory S. The Bcl-2 protein family: arbiters of cell survival.  Science. 1998;  281 1322-26
• 22 Yang J, Liu X, Bhalla K, Kim C N, Ibrado A M, Cai J. Prevention of apoptosis by Bcl-2: release of cytochrome C from mitochondria blocked.  Science. 1997;  275 1129-32
• 23 Chipuk J E, Bhat M, Hsing A Y, Ma J, Danielpour D. Bcl-xL blocks transforming growth factor-beta 1-induced apoptosis by inhibiting cytochrome C release and not by directly antagonizing Apaf-1-dependent caspase activation in prostate epithelial cells.  J Biol Chem. 2001;  276 26 614-21
• 24 Jurgensmeier J M, Xie Z, Deveraux Q, Ellerby L, Bredesen D, Reed J C. et al . Bax directly induces release of cytochrome C from isolated mitochondria.  Proc Natl Acad Sci USA. 1998;  95 4997-5002
• 25 Wolter K G, Hsu Y T, Smith C L, Nechushtan A, Xi X G, Youle R J. Movement of Bax from the cytosol to mitochondria during apoptosis.  J Cell Biol. 1997;  139 1281-92
• 26 Meriin A B, Gabai V L, Yaglom J, Shifrin V I, Sherman M Y. Proteasome inhibitors activate stress kinases and induce Hsp72.  J Biol Chem. 1998;  273 6373-9
• 27 Konopleva M, Contractor R, Kurinna S M, Chen W, Andreeff M, Ruvolo P P. The novel triterpenoid CDDO-Me suppresses MAPK pathways and promotes p38 activation in acute myeloid leukemia cells.  Leukemia. 2005;  19 1350-4
• 28 Huh J E, Kang K S, Chae C, Kim H M, Ahn K S, Kim S H. Roles of p38 and JNK mitogen-activated protein kinase pathways during cantharidin-induced apoptosis in U937 cells.  Biochem Pharmacol. 2004;  67 1811-8
• 29 Fujita H, Utsumi T, Muranaka S, Ogino T, Yano H, Akiyama J. et al . Involvement of Ras/extracellular signal-regulated kinase, but not Akt pathway in risedronate-induced apoptosis of U937 cells and its suppression by cytochalasin B.  Biochem Pharmacol. 2005;  69 1773-84